CryoLife with the stock code (CRY) now has 4 analysts in charge of the stock. Analysts agreed that the rating is "Buy." The target price is between 39 and 29, and the average target price we see is 33.44. Now at the previous closing price of 18.95, this indicates that there is a potential upside of 76.5%. The 50-day moving average is 21.84 and the 200-day moving average is 25.15. The company's market value is $741 million. For more information, please visit: http://www.cryolife.com
CryoLife manufactures, processes and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer composed of bovine blood protein, a cross-linked protein reagent for heart, blood vessel, lung and general surgery applications; On-X artificial aortic valve and mitral heart valve, and On-X ascending aortic prosthesis; heart preservation service; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, a ready-made stent graft for the treatment of chest and abdomen diseases; E-vita THORACIC 3G is used in the endovascular of thoracic aortic aneurysms Treatment; E-nya, a pleural stent graft system for minimally invasive repair of descending aortic disease; E-ventus BX, a balloon-expandable peripheral stent graft, used for endovascular treatment of renal and pelvic arteries; E-liac treats aneurysmal iliac arteries and aneurysmal iliac collaterals; and E-tegra, an abdominal aortic aneurysm stent graft system. In addition, it also provides synthetic vascular grafts for open aortic and peripheral vascular surgery; PerClot, an absorbable powder hemostatic agent for surgery; and cardiac laser treatment products, such as SolarGen 2100s Console and SoloGrip III once Sex phone. In addition, the company also sells CryoVein femoral vein and CryoArtery femoral artery vessel preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral valve replacement; and ascyrus medical anatomical stents, as well as other medical device manufacturers Provide pyrolytic carbon coating service. The company provides services to doctors, hospitals and other medical institutions, as well as cardiac, vascular, thoracic and general surgeons. CryoLife was founded in 1984 and is headquartered in Kennesaw, Georgia.
You can now share this content on Stocktwits, just click on the logo below and add the code to the text to view.
The good news spread quickly (but only if you did it):
View all sustainability departments, PLCs and news »
View all funds, market insights and news »
You understand and agree that any content posted on this website does not constitute a recommendation that any particular securities, portfolio of securities, trading or investment strategies are suitable or suitable for any particular person. You further understand that neither the information provider nor its affiliates will provide you with personal advice on the nature, potential, desirability, value, or applicability of any specific stocks, shares, securities, portfolios, transactions, investment strategies or other matters. We publicly disclose that we and our contributors may have interests in the investments and/or service providers mentioned on this website, and we receive compensation from certain companies mentioned on this website.